Who owns RAPPORT THERAPEUTICS INC?
- Ticker: RAPP
- CUSIP Number: 75383l102
Tip: Access positions for across all investors
Analyze quarterly positions in Rapport Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rapport Therapeutics stock
Who bought or sold RAPPORT THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Arch Venture Corp | 3.7M | $87M | 100% | Jun 2024 |
|
| Cormorant Asset Management | 2.9M | $68M | 100% | Jun 2024 |
|
| Capital Research and Management Company - Division 3 | 2.6M | $53M | 100% | Sep 2024 |
|
| Johnson & Johnson | 2.5M | $51M | 0% | Sep 2024 |
|
| Sofinnova Ventures | 2.0M | $41M | 2% | Sep 2024 |
|
| T. Rowe Price Investment Management | 1.7M | $35M | 13% | Sep 2024 |
|
| Alliancebernstein | 1.1M | $25M | 100% | Jun 2024 |
|
| T. Rowe Price Associates | 1.0M | $22M | -23% | Sep 2024 |
|
| Perceptive Advisors | 748k | $15M | 0% | Sep 2024 |
|
| BlackRock | 576k | $12M | 100% | Sep 2024 |
|
| Citadel Advisors | 488k | $9.5M | -18% | Sep 2024 |
|
| Siren | 384k | $7.9M | 100% | Sep 2024 |
|
| Logos Global Management | 209k | $4.4M | 100% | Jun 2024 |
|
| Geode Capital Management | 202k | $4.1M | 100% | Sep 2024 |
|
| Woodline Partners | 187k | $3.8M | 9% | Sep 2024 |
|
| Eventide Asset Management | 110k | $2.3M | 121% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 76k | $1.8M | 100% | Jun 2024 |
|
| Charles Schwab Investment Management | 73k | $1.5M | 100% | Sep 2024 |
|
| Northern Trust | 72k | $1.5M | 100% | Sep 2024 |
|
| Saturn V Capital Management | 70k | $1.6M | 100% | Jun 2024 |
|
| Vanguard Group | 70k | $1.6M | 100% | Jun 2024 |
|
| TD Asset Management | 62k | $1.3M | -39% | Sep 2024 |
|
| Winton Capital | 24k | $494k | 100% | Sep 2024 |
|
| LMR Partners | 20k | $410k | -60% | Sep 2024 |
|
| Bank of New York Mellon | 20k | $409k | 100% | Sep 2024 |
|
| Bank of America Corporation | 19k | $391k | 100% | Sep 2024 |
|
| Squarepoint Ops | 16k | $380k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 16k | $325k | 100% | Sep 2024 |
|
| Two Sigma Investments | 13k | $302k | 100% | Jun 2024 |
|
| Barclays | 13k | $264k | 37% | Sep 2024 |
|
| Citigroup | 13k | $262k | 100% | Sep 2024 |
|
| Davidson Kempner Capital Management | 10k | $229k | 100% | Jun 2024 |
|
| Balyasny Asset Management | 10k | $233k | 100% | Jun 2024 |
|
| MetLife Investment Advisors | 5.7k | $117k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 5.1k | $104k | 100% | Sep 2024 |
|
| Sandia Investment Management | 5.0k | $102k | 0% | Sep 2024 |
|
| SG Americas Securities | 4.9k | $101k | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 4.0k | $83k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 3.5k | $71k | 100% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.7k | $35k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.7k | $35k | 100% | Sep 2024 |
|
| Values First Advisors | 1.5k | $31k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 1.5k | $32k | 554% | Sep 2024 |
|
| Tidemark | 1.1k | $22k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 941.00 | $19k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 685.00 | $14k | 100% | Sep 2024 |
|
| Amalgamated Bank | 317.00 | $6.0k | 100% | Sep 2024 |
|
| Sterling Capital Management | 19.00 | $389.000300 | 100% | Sep 2024 |
|
Who sold out of Rapport Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 350k | $8.1M |
| Millennium Management | Jun 2024 | 117k | $2.7M |
| Monashee Investment Management | Jun 2024 | 40k | $930k |
| Alyeska Investment Group | Jun 2024 | 35k | $808k |
| Soros Fund Management | Jun 2024 | 30k | $698k |